相关实验视频

Updated: Jun 20, 2025

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

弗拉塔克辛的损失促进了由 ангиотензин II 诱导的内皮细胞转变为介质细胞的转变

Yuetong Guo¹, Xingyi Cheng¹, Chenglin Huang¹

¹Department of Cardiovascular Medicine, State Key Laboratory of Medical Genomics, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China.

Journal of the American Heart Association

|July 18, 2024

概括

弗拉塔克辛和西尔图因3形成一个反循环,在内皮转移到介质酶转变 (EndoMT) 期间调节代谢重塑. 这一途径影响心脏纤维化,可以向改善高血压的结果.

科学领域:

细胞的新陈代谢
心血管生物学心血管生物学
线粒体功能的功能

背景情况:

内皮细胞的代谢灵活性对于表型可塑性至关重要.
弗拉塔克辛在内皮细胞的铁代谢和命运中起着关键作用.
内皮转介质转换 (EndoMT) 与代谢变化有关.

研究的目的:

在EndoMT期间调查frataxin介导的代谢重塑.
阐明弗拉塔克辛/西尔图因3通路在高血压引起的EndoMT中的作用.
评估向这种途径的治疗潜力.

主要方法:

使用内皮细胞特异性frataxin淘汰和突变小鼠模型.
使用血管新素II输液诱导的高血压.
通过组织学和蛋白质分析评估EndoMT和心脏纤维化.
使用海马XF96分析仪测量脂肪酸氧化 (FAO).

主要成果:

ангиотензинII诱导的EndoMT和心脏纤维化,与减少frataxin表达和FAO相关.
弗拉塔克辛缺乏症加剧了血管新生素II诱导的EndoMT和纤维化.
确定了涉及frataxin,sirtuin 3和FAO的反循环,有助于EndoMT.
西利马林治疗恢复了粮农组织,素3和frataxin的表达,改善了EndoMT.

结论:

弗拉塔克辛/西尔图因3反循环是血管激素II诱导的EndoMT的一个关键调节器.
通过这种循环改善脂肪酸氧化 (FAO) 可以减弱EndoMT.
针对这种途径有潜力治疗高血压相关的心血管并发症.

关键词:

在EndoMTMT中使用.脂肪酸氧化过程中的脂肪酸氧化.弗拉塔克辛 (frataxin) 是一种塞尔图因 3 3

更多相关视频

TGF-β-mediated Endothelial to Mesenchymal Transition EndMT and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing

TGF-β-mediated Endothelial to Mesenchymal Transition EndMT and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing

Published on: February 26, 2021

Author Spotlight: A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition

Author Spotlight: A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition

Published on: July 21, 2023

相关概念视频

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...